Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ED.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ED.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ED.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ED.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ED.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ED.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ED.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DR.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used